Cereno Scientific AB (publ) (STO:CRNO.B)
4.362
+0.124 (2.93%)
At close: Sep 4, 2026
Cereno Scientific AB Market Cap
Cereno Scientific AB has a market cap or net worth of 1.32 billion as of September 4, 2026. Its market cap has decreased by -53.01% in one year.
Market Cap
1.32B
Enterprise Value
1.46B
Revenue
-293.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.36
ChartMarket Cap Chart
Since June 22, 2016, Cereno Scientific AB's market cap has increased from 68.69M to 1.32B, an increase of 1,825.48%. That is a compound annual growth rate of 33.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.36B | -34.03% |
| Dec 30, 2025 | 2.06B | 33.18% |
| Dec 30, 2024 | 1.55B | 44.86% |
| Dec 29, 2023 | 1.07B | 244.90% |
| Dec 30, 2022 | 310.10M | -42.01% |
| Dec 30, 2021 | 534.73M | 553.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.47B |
| Nanexa AB | 1.11B |
| Dicot Pharma AB | 830.40M |
| EQL Pharma AB | 747.10M |
| Cinclus Pharma Holding AB | 567.76M |
| Moberg Pharma AB | 540.69M |
| Orexo AB | 532.21M |
| Enzymatica AB | 449.06M |